Pabinafusp alfa Uses, Dosage, Side Effects and more
Pabinafusp alfa is under investigation in clinical trial NCT03568175 (A Study of JR-141 in Patients With Mucopolysaccharidosis II).
| Attribute | Details |
|---|---|
| Trade Name | Pabinafusp alfa |
| Generic | Pabinafusp alfa |
| Pabinafusp alfa Other Names | Pabinafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
